Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Infectious Disease
•
General Infectious Disease
•
Primary Care
Do you prefer a specific clinical scoring system to determine if a patient needs to be tested for Group A Streptococcal pharyngitis?
If so, why do you prefer one scoring system over the others?
Related Questions
When do you recommend limited or targeted respiratory pathogen testing versus a full respiratory pathogen panel in a patient presenting with URI symptoms?
What false positive findings, if any, do you see in patients who have active hepatitis C?
What factors should guide the choice between fosfomycin and nitrofurantoin for uncomplicated cystitis, given the reduced efficacy of fosfomycin?
How have the results of the BALANCE trial, which demonstrated the noninferiority of 7 days of antibiotics compared to 14 days for non-S. aureus bloodstream infections, influenced your practice?
Do you recommend low or intermediate dosing of TMP-SMX over high dosing for the initial treatment of non-disseminated pulmonary nocardiosis?
How would you manage a frail but functioning elderly patient with extensive thoracolumbar spinal fusions 4-5 years ago now presenting with copious purulent drainage from L2-L4 whose MRI shows no osteomyelitis or abscess, and who has mild pain but no systemic signs or symptoms of illness?
Under what circumstance would you order dalbavancin instead of vancomycin or daptomycin for MRSA endocarditis?
What is your approach to relapsing babesiosis in immunosuppressed patients?
Which dosing strategy do you typically use for dalbavancin for staph aureus vertebral osteomyelitis?
Do you routinely test for co-infection of other tick-borne illnesses in a patient who tests positive for Lyme, anaplasmosis, babesiosis, or ehrlichiosis?